Product Information

ATORVASTATIN 80 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0669 per EA under NDC 31722042705. Its NADAC has been published 133 times since May 8, 2024.

FDA first approved this application on Sep 12, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ATORVASTATIN 80 MG TABLET

ATORVASTATIN CALCIUM
$0.0669per EA

Strength

80 mg/1

NDC

31722042705

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214344

FDA Approved

9/12/2023

TE Code

AB

On Market Since

9/12/2023

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ATORVASTATIN 80 MG TABLET has been published 133 times since May 8, 2024, and over the history we have for it it has declined 14.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0669 per EA
All-time high$0.0854 (Jul 10, 2024)
All-time low$0.0635 (Jul 17, 2024)
52-week high$0.0726
52-week low$0.0669
Median price$0.0726
Average price$0.0751
Largest weekly change-25.7% (Jul 17, 2024)
Weeks tracked133
Tracking sinceMay 8, 2024

Price History

1W

-1.6%

1M

-3.4%

3M

-3.4%

6M

-5.2%

1Y

-6.2%

3Y

N/A

5Y

N/A

All

-14.2%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ATORVASTATIN 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 80 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0669 per EA (NDC 31722042705), effective Nov 18, 2026.

How has the price of ATORVASTATIN 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for ATORVASTATIN 80 MG TABLET has declined 14.2%. It has been tracked across 133 weekly CMS publications since May 8, 2024.

What are the highest and lowest recorded NADAC prices for ATORVASTATIN 80 MG TABLET?

Since May 8, 2024, the NADAC for ATORVASTATIN 80 MG TABLET has ranged from a low of $0.0635 (Jul 17, 2024) to a high of $0.0854 (Jul 10, 2024), with a median of $0.0726 per EA.

Are there cheaper alternatives to ATORVASTATIN 80 MG TABLET?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 80 MG TABLET, is $0.0635 per EA — about 5% below ATORVASTATIN 80 MG TABLET.

Who manufactures ATORVASTATIN 80 MG TABLET?

ATORVASTATIN 80 MG TABLET (NDC 31722042705) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.